Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
Related Posts
Smith CA, Kuklinski LF. Skin cancer diagnosis associated with asthma and hay fever: a nationwide cross-sectional study. Arch Dermatol Res. 2024 Sep 14;316(9):620. doi: 10.1007/s00403-024-03373-7.[...]
Lebwohl MG, Armstrong AW, Alexis AF, Lain EL, Jacobson AA. Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review[...]
Kelly-Scumpia KM, Archang MM, Purbey PK, Yokota T, Wu R, McCourt J, Li S, Crosbie RH, Scumpia PO, Deb A. Modulating the extracellular matrix to[...]